The rise of Sildenafil initially drove a surge for the drug industry, but recent shifts present a murky picture for shareholders. Off-patent competitors are eating into earnings, and persistent litigation add further https://jemimagius056289.blogrenanda.com/48081331/viagra-and-big-pharma-a-volatile-play